• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

More Evidence of the Inverse Relationship Between Dementia and Cancer Mortality


  • Please log in to reply
1 reply to this topic

#1 reason

  • Guardian Reason
  • 1,101 posts
  • 249
  • Location:US

Posted 15 April 2014 - 12:04 PM


It is perhaps unexpected that incidence of dementia and incidence of cancer seem to have a robust inverse relationship, one that has shown up in multiple different study populations. In general we think of aging as a global phenomenon in the body keyed to rising levels of damage in all tissues: if you are farther down the road than your peers for whatever reason then you would expect a higher risk of all of the potential failure modes in the complex systems of your body.

In one sense, yes, this is true. But in some people risk of cancer rises significantly more rapidly than risk of dementia, and in others vice versa. As this study shows the differentiation in risk starts early in the progression of age-related cognitive decline:

Older people who are starting to have memory and thinking problems, but do not yet have dementia may have a lower risk of dying from cancer than people who have no memory and thinking problems. "Studies have shown that people with Alzheimer's disease are less likely to develop cancer, but we don't know the reason for that link. One possibility is that cancer is underdiagnosed in people with dementia, possibly because they are less likely to mention their symptoms or caregivers and doctors are focused on the problems caused by dementia. The current study helps us discount that theory."

The study involved 2,627 people age 65 and older in Spain who did not have dementia at the start of the study. They took tests of memory and thinking skills at the start of the study and again three years later, and were followed for an average of almost 13 years. The participants were divided into three groups: those whose scores on the thinking tests were declining the fastest, those whose scores improved on the tests, and those in the middle.

During the study, 1,003 of the participants died, including 339 deaths, or 34 percent, among those with the fastest decline in thinking skills and 664 deaths, or 66 percent, among those in the other two groups. A total of 21 percent of those in the group with the fastest decline died of cancer, according to their death certificates, compared to 29 percent of those in the other two groups. People in the fastest declining group were still 30 percent less likely to die of cancer when the results were adjusted to control for factors such as smoking, diabetes and heart disease, among others.

Link: http://www.eurekaler...n-opw040314.php


View the full article at FightAging

#2 Brett Black

  • Guest
  • 353 posts
  • 174
  • Location:Australia

Posted 16 April 2014 - 06:52 AM

IGF-1 and/or GH may be involved:

...Analysis of 12 studies with 14,906 participants clearly demonstrates that in humans, there is a U-shaped association between circulating IGF-1 levels and all-cause mortality. Important for the present discussion, low levels of IGF-1 translate into a significantly increased mortality risk in the general population, predominantly due to an increased incidence of cardiovascular diseases. In contrast, higher IGF-1 levels are associated with an increased cancer mortality...

...GH and IGF-1 have important trophic actions on many tissues. Both gene expression and levels of GH and IGF-1 decrease in the brain with age, and this decrease is closely associated with neuronal dysfunction. Certainly, it has been clear that administration of these hormones increases neuronal function and reverses age-related changes in several neurological measures when administered to aged individuals. IGF-1 has been shown to increase glucose metabolism, neurite outgrowth, neurogenesis, synaptic complexity, and reverse the age-related rise in oxidative stress. Based on the current literature, there is no disagreement that GH and IGF-1 are important for the support of cognitive function in healthy adults...

...Based on the literature, GH and IGF-1 have both beneficial and deleterious effects on specific pathologies that undoubtedly influence life span. Therefore, in many cases, the consequences of GH and IGF-1 deficiency are dependent on the species, background strain, and pathologies that the species or strain is susceptible. Those animals that are at risk for cancer, liver, or kidney disease will likely exhibit a shortened life span in response to elevated levels of GH and IGF-1, and we expect that those animals with reduced risk for these diseases will likely not exhibit increased life span in response to this intervention. Similarly, those species at risk for specific cardiovascular diseases (stroke, myocardial infarction, heart failure, vascular cognitive impairment) may benefit from elevated levels of these hormones. These effects are consistent with the classical actions of GH and IGF-1 being important anabolic agents that stimulate cell growth, proliferation, and tissue repair. Because cardiovascular diseases, metabolic diseases, and cancer are all important health issues in the elderly population, the effects of GH/IGF-1 pathway on human health span and life span are predictably complex...

---

1: Sonntag WE, Csiszar A, deCabo R, Ferrucci L, Ungvari Z. Diverse roles of
growth hormone and insulin-like growth factor-1 in mammalian aging: progress and
controversies. J Gerontol A Biol Sci Med Sci. 2012 Jun;67(6):587-98. doi:
10.1093/gerona/gls115. Epub 2012 Apr 20. Review. PubMed PMID: 22522510; PubMed
Central PMCID: PMC3348498.
http://www.ncbi.nlm....pubmed/22522510



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).



0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users